EuropeSouth AsiaAsia PacificAmericasMiddle EastAfricaBBC HomepageWorld ServiceEducation
News image
News image
News image
News imageNews image
News image
Front Page
News image
World
News image
UK
News image
UK Politics
News image
Business
News image
Sci/Tech
News image
Health
News image
Education
News image
Sport
News image
Entertainment
News image
Talking Point
News image
News image
News image
On Air
Feedback
Low Graphics
Help
News imageNews imageNews image
News imageWednesday, January 20, 1999 Published at 19:31 GMT
News image
News image
Health
News image
Chemical tricksters may revolutionise contraception
News image
Condoms may be replaced
News image
Safe and side effect-free contraceptives that "trick" eggs into thinking they have been fertilised by a sperm are now a possibility, scientists have predicted.

US researchers have identified a receptor on the surface of eggs that binds to a sperm surface protein.

They believe it should be possible to target the receptors so that the egg is stimulated to make changes to its outer coat that would prevent fertilisation by a sperm, New Scientist magazine reports.

Existing birth control methods, such as barrier contraceptives and hormones, are either not totally reliable or have side effects.

Scientists have already identified at least three binding proteins on the sperm.

But identifying the corresponding receptors on the egg has been difficult, partly because eggs are harder to come by.

Egg breakthrough


[ image: Sperm may be blocked from penetrating the egg]
Sperm may be blocked from penetrating the egg
Now scientists at the State University of New York in Stony Brook have found an egg receptor for a critical sperm surface protein called fertilin-beta.

In mice with a faulty fertilin-beta gene, sperm rarely fuse with eggs. The team synthesised the part of the sperm protein thought to bind to the egg, attached a radioactive tag, and then mixed it with mouse eggs.

The tagged fragment bound only to a receptor called alpha-6/beta-1 integrin.

Evidence from frog eggs suggests that an integrin receptor can activate the egg and prompt it to change its outer coat to prevent more than one sperm from getting in.

If this happens in humans, the integrin receptor could be a target for a new contraceptive that deceives the egg.

However, mammalian eggs have yet to be successfully activated in this way.

Janice Evans, of the Johns Hopkins School of Public Health in Baltimore, Maryland, said sperm probably have several ways of getting into an egg, so researchers might have to come up with a cocktail of drugs to block all the different sperm-egg interactions.

She said: "If there was only one way to get a sperm to an egg, none of us would be here."

Richard Schultz, of the University of Pennsylvania in Philadelphia, believes targeting sperm proteins would be a better approach, because the alpha-6/beta-1 integrin receptor is also found on cells other than the egg.

Drugs that block this receptor might disrupt other cell interactions and cause side effects.

A spokeswoman for the Family Planning Association said: "We would welcome any research that leads to a better, safer, more effective form of contraception."

News image


Advanced options | Search tips


News image
News image
News imageBack to top | BBC News Home | BBC Homepage |
News image

News imageNews imageNews image
Health Contents
News image
News imageBackground Briefings
News imageMedical notes
News imageNews image
Relevant Stories
News image
14 Jan 99�|�Health
Casualties 'waste time' over contraception
News image
01 Dec 98�|�Health
Chemist launches drop-in sex clinic
News image
29 Jun 98�|�Health
Shy men to get help with sex talk
News image
01 Jun 98�|�Latest News
Morning after pill should be 'more easily available'
News image

News image
News image
News image
News imageInternet Links
News image
News imageNews image
Reproductive Health online
News image
Pregnancy and Childbirth information
News image
Medical sites
News image
Family Planning Association
News image
New Scientist
News image
News imageNews image
The BBC is not responsible for the content of external internet sites.

News image
News image
News image
News imageIn this section
News image
Disability in depth
News image
Spotlight: Bristol inquiry
News image
Antibiotics: A fading wonder
News image
Mental health: An overview
News image
Alternative medicine: A growth industry
News image
The meningitis files
News image
Long-term care: A special report
News image
Aids up close
News image
From cradle to grave
News image
NHS reforms: A guide
News image
NHS Performance 1999
News image
From Special Report
NHS in crisis: Special report
News image
British Medical Association conference '99
News image
Royal College of Nursing conference '99
News image

News image
News image
News image